Clinical Trials
2 trialsNCT07447570 2026-03-03
Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT06796270 2025-01-28
Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma
The Second Affiliated Hospital of Hainan Medical University
Phase NA Recruiting